Anti-inflammatory Effects of Roflumilast Treatment for 12 Weeks in Stable-state Non-cystic Fibrosis Bronchiectasis
Latest Information Update: 11 Dec 2024
At a glance
- Drugs Roflumilast (Primary)
- Indications Bronchiectasis
- Focus Therapeutic Use
Most Recent Events
- 09 Dec 2024 Status changed from recruiting to completed.
- 31 Oct 2022 Planned End Date changed from 30 Jun 2022 to 30 Nov 2024.
- 31 Oct 2022 Planned primary completion date changed from 28 Feb 2022 to 30 Jun 2024.